FI924344A - Kompositioner omfattande ett cytotoxiskt medel och permeabilitetpotentierande medel - Google Patents

Kompositioner omfattande ett cytotoxiskt medel och permeabilitetpotentierande medel Download PDF

Info

Publication number
FI924344A
FI924344A FI924344A FI924344A FI924344A FI 924344 A FI924344 A FI 924344A FI 924344 A FI924344 A FI 924344A FI 924344 A FI924344 A FI 924344A FI 924344 A FI924344 A FI 924344A
Authority
FI
Finland
Prior art keywords
oil composition
medicine over
permeability potential
cytotoxic medicine
over permeability
Prior art date
Application number
FI924344A
Other languages
English (en)
Other versions
FI924344A0 (fi
Inventor
Michel J N Cormier
Lina T Taskovich
Su Il Yum
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI924344A0 publication Critical patent/FI924344A0/fi
Publication of FI924344A publication Critical patent/FI924344A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI924344A 1990-03-30 1992-09-28 Kompositioner omfattande ett cytotoxiskt medel och permeabilitetpotentierande medel FI924344A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50248890A 1990-03-30 1990-03-30
PCT/US1991/001987 WO1991015210A1 (en) 1990-03-30 1991-03-25 Compositions comprising cytotoxic agent and permeation enhancers

Publications (2)

Publication Number Publication Date
FI924344A0 FI924344A0 (fi) 1992-09-28
FI924344A true FI924344A (fi) 1992-09-28

Family

ID=23998069

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924344A FI924344A (fi) 1990-03-30 1992-09-28 Kompositioner omfattande ett cytotoxiskt medel och permeabilitetpotentierande medel

Country Status (9)

Country Link
EP (1) EP0522006A1 (fi)
JP (1) JPH05505807A (fi)
AU (1) AU633207B2 (fi)
CA (1) CA2038969A1 (fi)
FI (1) FI924344A (fi)
IE (1) IE910976A1 (fi)
PT (1) PT97139A (fi)
WO (1) WO1991015210A1 (fi)
ZA (1) ZA912228B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU719251B2 (en) * 1996-06-19 2000-05-04 Novartis Ag Cyclosporin-containing soft capsule preparations
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
AU753018B2 (en) * 1996-06-19 2002-10-03 Novartis Ag Cyclosporin-containing soft capsule preparations
AU722285B2 (en) * 1996-06-19 2000-07-27 Novartis Ag Cyclosporin-containing soft capsule preparations
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
WO2005079855A1 (es) * 2004-02-23 2005-09-01 David Quintanar Guerrero Composicion promotora de penetracion a base de esteres de acidos grasos de sacarosa
AU2020328026A1 (en) * 2019-08-14 2022-03-03 Nanometics Llc (D.B.A. Phd Biosciences) Uracil dermal pharmaceutical formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37447B1 (en) * 1972-04-05 1977-07-20 Procter & Gamble Dermatological compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4849426A (en) * 1987-05-15 1989-07-18 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents

Also Published As

Publication number Publication date
FI924344A0 (fi) 1992-09-28
AU7562091A (en) 1991-10-30
AU633207B2 (en) 1993-01-21
CA2038969A1 (en) 1991-10-01
JPH05505807A (ja) 1993-08-26
PT97139A (pt) 1991-11-29
WO1991015210A1 (en) 1991-10-17
EP0522006A1 (en) 1993-01-13
ZA912228B (en) 1991-12-24
IE910976A1 (en) 1991-10-09

Similar Documents

Publication Publication Date Title
FI923434A0 (fi) Foerfarande och anordning foer snabb pyrolys av kolhaltigt material i ett reaktorsystem med cirkulations baeddtransport.
FI932635A0 (fi) Foerpackning bestaoende av miljoevaenligt material och innehaollande sammanpressade flexibla artiklar
FI935540A0 (fi) Filtersammansaettning med ett filterelement och en taettningsanordning
FI925480A (fi) Vattenloeslig pentacyklisk triterpenkomposition och foerfarande foer framstaellning av densamma
FI923747A0 (fi) Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika.
FI931683A (fi) Anordning och foerfarande foer avskaerning av en bana
FI930578A0 (fi) Konstruktion foer skapande av vaeggar speciellt foer operationssalar och motsvarande
FI931161A0 (fi) Kompositioner innehaollande estrar av karboxylhaltiga interpolymerer och anvaendning av dessa
FI933657A0 (fi) Foerfarande och anordning foer lokalisering av ett laeckstaelle med hjaelp av ultraljud
FI924344A (fi) Kompositioner omfattande ett cytotoxiskt medel och permeabilitetpotentierande medel
FI925704A0 (fi) Foerfarande och anlaeggning foer bestrykning av vals i en filmlimpress
FI935259A0 (fi) Foerfarande och anordning foer modifiering av ett beslutstyrt klockkorrigeringssystem
FI910410A0 (fi) Foerfarande och anordning med vilken loesgoerandet av ett fiberaktigt material fraon en filteryta hjaelpes med en periodisk pressning.
IT9020144A0 (it) Composizione farmaceutica contenente egf
FI933477A0 (fi) Monohydrat av ett dinatriumsalt av 4-klorfenyltiometylenbisfosfonsyra,dess framstaellning och farmaceutiska kompositioner innehaollande detta
FI934628A0 (fi) Roterande skaercylinder med en laosbalk foer ett belastningsfritt arktillskaerningsblad och ett foerfarande foer tillverkning av densamma
FI933187A0 (fi) Foerfarande foer framstaellning av anivirala aemnen innehaollande guanin och i ett dylikt foerfarande anvaendbara purinylsalter
FI911644A (fi) Terapeutisk foerening och komposition.
FI915801A0 (fi) Komposition och foerfarande foer att foerhindra fluoros.
DE69118261T2 (de) Optisch aktive Delta-Valerolacton-Ring enthaltende Verbindung und dieselbe enthaltende flüssigkristalline Zusammensetzung
FI910773A0 (fi) Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex.
FI89089B (fi) Foerfarande och form foer gjutning av plattbelaeggning
FI925367A0 (fi) Termiskt och visuellt camouflage
FI930697A0 (fi) Foerfarande och komposition foer behandling av virusinjektion
FI915097A (fi) Komposition och foerfarande foer konservering av traed

Legal Events

Date Code Title Description
FD Application lapsed